ヒト・マイクロバイオームの世界市場：プロバイオティクス、食品、プレバイオティクス、医療食品、診断デバイス、医薬品、サプリメント...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.3 Key Industry Insights
2.2.4 Assumptions

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 31)
4.1 Market Overview
4.2 Geographic Analysis: Market, By Product
4.3 Geographic Snapshot of the Market
4.4Market, By Product, 2019 vs 2023
4.5 Human Microbiome Research Spending Market, By Technology, 2015 vs 2020
4.6 Life Cycle Analysis

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Therapy, an Emerging Market
5.3.1.2 Human Microbiome as A New Validated Target
5.3.1.3 Need for Early Disease Detection and Diagnosis Driving the Use of Microbiomes in Molecular Diagnostics
5.3.2 Restraints
5.3.2.1 Lack of Expertise, Proper Detailed Research
5.3.2.2 Barriers to Prove Causal Link Between Dysbiosis and Disease
5.3.3 Opportunities
5.3.3.1 Investigational New Drug (IND) Requirements for Fecal Microbiota May Boost Market Growth
5.3.3.2 Joint Ventures, Collaborations, & Partnerships
5.3.4 Threats
5.3.4.1 Government Regulations
5.3.5 Burning Issues
5.3.5.1 Abundant Opportunities in the Microbiome Field and Tremendous Research Investments
5.3.5.2 Development of Microbiome Therapeutic Products

6 Human Microbiome Market, By Product (Page No. – 44)
6.1 Introduction
6.2 Probiotics
6.3 Foods
6.4 Prebiotics
6.5 Medical Foods
6.6 Diagnostic Devices
6.7 Drugs
6.8 Other Probiotic Supplements

7 Human Microbiome Market, By Application (Page No. – 54)
7.1 Introduction
7.2 Therapeutics
7.3 Diagnostics

8 Human Microbiome Market, By Disease (Page No. – 59)
8.1 Introduction
8.2 Acute Diarrhea
8.3 Obesity
8.4 Diabetes
8.5 Autoimmune Disorders
8.6 Cancer
8.7 Mental Disorders
8.8 Other Diseases

9 Human Microbiome Research Spending Market, By Product (Page No. – 70)
9.1 Introduction
9.2 Instruments
9.2.1 Laboratory Instruments
9.2.2 Analyzers
9.3 Consumables
9.3.1 Kits
9.3.2 Reagents

10 Human Microbiome Research Spending Market, By Technology (Page No. – 80)
10.1 Introduction
10.2 Cell Culture Technology
10.3 High-Throughput Technology
10.4 Omics Technology
10.5 Computational Tools

11 Geographic Analysis (Page No. – 88)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 112)
12.1 Overview
12.2 Competitive Situation and Trends
12.2.1 Agreements, Partnerships, and Collaborations
12.2.2 Acquisitions & Expansions
12.2.3 New Product Launches, Product Approvals, and Patents
12.2.4 Other Developments

13 Company Profiles (Page No. – 119)
13.1 Geographic Revenue Mix of the Three Market Players
13.2 Enterome Bioscience
13.2.1 Business Overview
13.2.2 Financials
13.2.3 Products Offered
13.2.4 Recent Developments
13.2.5 MnM View
13.3 E.I. Du Pont De Nemours and Company
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Recent Developments
13.3.4 MnM View
13.4 Merck & Co., Inc.
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.5 Metabiomics Corporation
13.5.1 Business Overview
13.5.2 Financials
13.5.3 Products Offered
13.5.4 Recent Developments
13.5.5 MnM View
13.6 Yakult Honsha Co., Ltd.
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.6.4 MnM View
13.7 Microbiome Therapeutics, Llc
13.7.1 Business Overview
13.7.2 Financials
13.7.3 Products Offered
13.7.4 Recent Developments
13.8 Osel, Inc.
13.8.1 Business Overview
13.8.2 Financials
13.8.3 Products Offered
13.8.4 Recent Developments
13.9 Second Genome, Inc.
13.9.1 Business Overview
13.9.2 Financials
13.9.3 Products Offered
13.9.4 Recent Developments
13.10 Vithera Pharmaceuticals
13.10.1 Business Overview
13.10.2 Financials
13.10.3 Products Offered
13.10.4 Recent Developments
13.11 Vedanta Biosciences, Inc.
13.11.1 Business Overview
13.11.2 Financials
13.11.3 Products Offered
13.11.4 Recent Developments

14 Appendix (Page No. – 140)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports